This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pharmacyclics, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Pearl Shwe-Cho Tay: A Pioneer in Bruton's Tyrosine Kinase Inhibition
Introduction: Pearl Shwe-Cho Tay, an inventive mind based in Union City, California, has made significant contributions to the field of pharmaceuticals. With a focus on a targeted approach to autoimmune diseases, cancers, and inflammatory conditions, Tay's work exemplifies the impactful role of innovative thinkers in the medical landscape.
Latest Patents: Tay holds a patent concerning Bruton's tyrosine kinase (Btk) inhibitors. The patent titled "Formulations of a Bruton's Tyrosine Kinase Inhibitor" describes a novel pharmaceutical formulation known as 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. This invention not only details the inhibitor itself but also covers various pharmaceutical compositions containing it. The applications of this Btk inhibitor extend to the treatment of autoimmune diseases, heteroimmune diseases, different cancers including lymphoma, and various inflammatory conditions.
Career Highlights: Throughout his career, Pearl Shwe-Cho Tay has been associated with Pharmacyclics, Inc., a biopharmaceutical company known for its commitment to developing innovative therapies. His expertise in pharmacology has driven advancements in targeting specific pathways involved in disease processes, leading to improved therapeutic outcomes for patients.
Collaborations: In his professional journey, Tay has collaborated with talented colleagues such as Cassandra Shu and Harisha Atluri. These collaborations emphasize the importance of teamwork in research and development, pooling together knowledge and expertise to foster innovations.
Conclusion: Pearl Shwe-Cho Tay's innovations in formulating Btk inhibitors reflect a commitment to addressing pressing health challenges through scientific advancement. His work at Pharmacyclics, Inc., alongside esteemed coworkers, showcases the collaborative spirit needed to push the boundaries of modern medicine and provide solutions for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile